Cas:886374-01-2 5-Chloro-3-fluoro-2-methoxypyridine manufacturer & supplier

We serve Chemical Name:5-Chloro-3-fluoro-2-methoxypyridine CAS:886374-01-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Chloro-3-fluoro-2-methoxypyridine

Chemical Name:5-Chloro-3-fluoro-2-methoxypyridine
CAS.NO:886374-01-2
Synonyms:pyridine, 5-chloro-3-fluoro-2-methoxy-;5-Chloro-3-fluoro-2-methoxypyridine
Molecular Formula:C6H5ClFNO
Molecular Weight:161.561
HS Code:2933399090

Physical and Chemical Properties:
Melting point:29-33℃
Boiling point:165.4±35.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.497
PSA:22.12000
Exact Mass:161.004364
LogP:1.81

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like pyridine, 5-chloro-3-fluoro-2-methoxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Chloro-3-fluoro-2-methoxypyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pyridine, 5-chloro-3-fluoro-2-methoxy- Use and application,5-Chloro-3-fluoro-2-methoxypyridine technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. 5-Chloro-3-fluoro-2-methoxypyridine manufacturer In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. 5-Chloro-3-fluoro-2-methoxypyridine supplier Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23. 5-Chloro-3-fluoro-2-methoxypyridine vendor A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. 5-Chloro-3-fluoro-2-methoxypyridine factory In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday.